Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Durect Corp (DRRX)

Durect Corp (DRRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,313
  • Shares Outstanding, K 31,054
  • Annual Sales, $ 2,030 K
  • Annual Income, $ -8,320 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta 0.92
  • Price/Sales 29.51
  • Price/Cash Flow N/A
  • Price/Book 17.02
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.40
  • Most Recent Earnings $-0.07 on 08/12/25
  • Next Earnings Date 11/12/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8500 +3.24%
on 08/11/25
1.9700 -3.05%
on 09/08/25
+0.0400 (+2.14%)
since 08/08/25
3-Month
0.5000 +282.00%
on 07/16/25
2.6400 -27.65%
on 07/29/25
+1.3350 (+232.17%)
since 06/10/25
52-Week
0.4801 +297.83%
on 05/28/25
2.6400 -27.65%
on 07/29/25
+0.4100 (+27.33%)
since 09/10/24

Most Recent Stories

More News
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline

DRRX : 1.9100 (-1.04%)
BHC.TO : 9.39 (-1.78%)
BHC : 6.82 (-1.59%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders

NEW YORK , Aug. 18, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PVBC : 13.50 (+3.05%)
DRRX : 1.9100 (-1.04%)
VBTX : 30.26 (+1.00%)
Durect: Q2 Earnings Snapshot

Durect: Q2 Earnings Snapshot

DRRX : 1.9100 (-1.04%)
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

Bausch Health will pay $1.75 per share plus up to $350 million in aggregate sales milestones

DRRX : 1.9100 (-1.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders

NEW YORK , July 31, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DRRX : 1.9100 (-1.04%)
SNV : 52.73 (+0.36%)
PNFP : 100.19 (+0.41%)
NSC : 294.43 (+0.15%)
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat

Shares of Bausch Health Companies Inc. (BHC) declined 6.3% after the company reported mixed results for the second quarter of 2025.Adjusted earnings per share of 90 cents missed the Zacks Consensus Estimate...

DRRX : 1.9100 (-1.04%)
ARVN : 11.72 (-1.51%)
CRMD : 11.45 (+0.09%)
BHC : 6.82 (-1.59%)
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of DURECT Corporation (NASDAQ: DRRX) to Bausch Health Companies Inc. for $1.75 per share is fair to DURECT shareholders. ...

DRRX : 1.9100 (-1.04%)
Shareholder Alert: The Ademi Firm Investigates Whether DURECT Corporation Is Obtaining a Fair Price for Its Public Shareholders

The Ademi Firm is investigating DURECT (NYSE: DRRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Bausch Health . Click ...

DRRX : 1.9100 (-1.04%)
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

LAVAL, QC and CUPERTINO, Calif. , July 29, 2025 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), a global, diversified pharmaceutical company, and DURECT Corporation...

DRRX : 1.9100 (-1.04%)
BHC.TO : 9.39 (-1.78%)
BHC : 6.82 (-1.59%)
Durect: Q1 Earnings Snapshot

Durect: Q1 Earnings Snapshot

DRRX : 1.9100 (-1.04%)

Business Summary

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from...

See More

Key Turning Points

3rd Resistance Point 1.9767
2nd Resistance Point 1.9633
1st Resistance Point 1.9367
Last Price 1.9100
1st Support Level 1.8967
2nd Support Level 1.8833
3rd Support Level 1.8567

See More

52-Week High 2.6400
Last Price 1.9100
Fibonacci 61.8% 1.8149
Fibonacci 50% 1.5601
Fibonacci 38.2% 1.3052
52-Week Low 0.4801

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar